Advertisement
For patients with aquaporin-4-immunoglobulin G-positive neuromyelitis optica spectrum disorder

AAN: Eculizumab Reduces Risk for Relapse in Neuromyelitis Optica

0
But no significant between-group difference noted in measures of disability progression
Health professionals are generally supportive of medicinal cannabis use but report a lack of knowledge about its use

Health Professionals Supportive of Medicinal Cannabis

0
However, across medicine, pharmacy, and nursing, providers need more information
The use of alteplase between 4.5 and 9.0 hours after stroke onset results in a higher number of patients with no or minor neurological deficits

Alteplase Seems Beneficial at 4.5 to 9.0 Hours After Stroke

0
Trial terminated because of loss of equipoise after publication of positive results from previous trial
In 2018

CDC: Uninsurance Levels Did Not Change Significantly in 2018

0
Uninsurance increased among adults aged 45 to 64 years; increase seen in high-deductible health plans
Nut intake during the first trimester of pregnancy is associated with long-term child neuropsychological development

Nut Intake in First Trimester May Benefit Child Neurodevelopment

0
Children of mothers with the highest level of nut intake have better scores on cognitive tests
In 2018

2018 Saw More Employed Physicians Than Self-Employed

0
Proportion of physicians working in practices wholly owned by physicians dropped to 54 percent in 2018
In response to public demands for action to control drug costs

Prices Will Soon Be Included in TV Drug Ads

0
Regulations will require companies to disclose prices of meds costing more than $35 for a month's supply
For patients with symptomatic pulmonary embolism

Patent Foramen Ovale Ups Ischemic Stroke in Those With PE

0
Frequency of ischemic stroke increased in association with patent foramen ovale in symptomatic PE
In 2015 to 2016

In 2015 to 2016, 45.8 Percent of U.S. Population Used Rx Drugs

0
Prescription drug use increased with age, reaching 85.0 percent for those aged 60 years and older
The average price for single-source brand-name drugs is higher in the United States than in other countries

External Reference Pricing Could Cut Drug Costs in U.S.

0
Prices averaged 3.2 to 4.1 times higher in U.S.; differential varied from 1.3 to 70.1 for individual drugs